Influence of non-alcoholic fatty liver disease on the prognosis in patients with colorectal cancer

Clinics and Research in Hepatology and Gastroenterology

Volumn 36, Issue 1, 2012, Pages 78-83

  Min, Yang Won ^a   Yun, Hwan Sic ^a   Chang, Woo Ik ^a   Kim, Jin Yong ^a   Kim, Young Ho ^a   Son, Hee Jung ^a   Kim, Jae J ^a   Rhee, Jong Chul ^a   Chang, Dong Kyung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADENOMA; ADULT; ADVANCED CANCER; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; RETROSPECTIVE STUDY; TUMOR DIFFERENTIATION; ULTRASOUND;

AGED; ALGORITHMS; COLORECTAL NEOPLASMS; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84856713095     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2011.10.006     Document Type: Article

References (28)

1. Edwards B.K., Brown M.L., Wingo P.A., Howe H.L., Ward E., Ries L.A., et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005, 97:1407-1427.
2. Leslie A., Carey F.A., Pratt N.R., Steele R.J. The colorectal adenoma-carcinoma sequence. Br J Surg 2002, 89:845-860.
3. Ahmed R.L., Schmitz K.H., Anderson K.E., Rosamond W.D., Folsom A.R. The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006, 107:28-36.
4. Murphy T.K., Calle E.E., Rodriguez C., Kahn H.S., Thun M.J. Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 2000, 152:847-854.
5. Schiel R., Muller U.A., Braun A., Stein G., Kath R. Risk of malignancies in patients with insulin-treated diabetes mellitus: results of a population-based trial with 10-year follow-up (JEVIN). Eur J Med Res 2005, 10:339-344.
6. Lee G.E., Park H.S., Yun K.E., Jun S.H., Kim H.K., Cho S.I., et al. Association between BMI and metabolic syndrome and adenomatous colonic polyps in Korean men. Obesity (Silver Spring) 2008, 16:1434-1439.
7. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 2007, 86:s836-s842.
8. Campbell P.T., Deka A., Jacobs E.J., Newton C.C., Hildebrand J.S., McCullough M.L., et al. Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology 2010, 139:1138-1146.
9. Adams K.F., Leitzmann M.F., Albanes D., Kipnis V., Mouw T., Hollenbeck A., et al. Body mass and colorectal cancer risk in the NIH-AARP cohort. Am J Epidemiol 2007, 166:36-45.
10. Calle E.E., Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004, 4:579-591.
11. Krawczyk M., Bonfrate L., Portincasa P. Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 2010, 24:695-708.
12. Farrell G.C. The liver and the waistline: fifty years of growth. J Gastroenterol Hepatol 2009, 24(Suppl 3):S105-S118.
13. Wong V.W., Wong G.L., Choi P.C., Chan A.W., Li M.K., Chan H.Y., et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3years. Gut 2010, 59:969-974.
14. Williams C.D., Stengel J., Asike M.I., Torres D.M., Shaw J., Contreras M., et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011, 140:124-131.
15. Jimba S., Nakagami T., Takahashi M., Wakamatsu T., Hirota Y., Iwamoto Y., et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 2005, 22:1141-1145.
16. Donati G., Stagni B., Piscaglia F., Venturoli N., Morselli-Labate A.M., Rasciti L., et al. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut 2004, 53:1020-1023.
17. Assy N., Kaita K., Mymin D., Levy C., Rosser B., Minuk G. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 2000, 45:1929-1934.
18. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Bugianesi E., Lenzi M., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001, 50:1844-1850.
19. Hwang S.T., Cho Y.K., Park J.H., Kim H.J., Park D.I., Sohn C.I., et al. Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps. J Gastroenterol Hepatol 2010, 25:562-567.
20. Wong V.W., Wong G.L., Tsang S.W., Fan T., Chu W.C., Woo J., et al. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut 2011, 60:829-836.
21. Neuschwander-Tetri B.A., Caldwell S.H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003, 37:1202-1219.
22. Lee Y.I., Lim Y.S., Park H.S. Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: a retrospective cohort study. J Gastroenterol Hepatol 2011, 10.1111/j.1440-1746.2011.06816.x.
23. Kojima S., Watanabe N., Numata M., Ogawa T., Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol 2003, 38:954-961.
24. Younossi Z.M., Gramlich T., Matteoni C.A., Boparai N., McCullough A.J. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol 2004, 2:262-265.
25. Gupte P., Amarapurkar D., Agal S., Baijal R., Kulshrestha P., Pramanik S., et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004, 19:854-858.
26. Hamaguchi M., Kojima T., Takeda N., Nakagawa T., Taniguchi H., Fujii K., et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005, 143:722-728.
27. Palmentieri B., de Sio I., La Mura V., Masarone M., Vecchione R., Bruno S., et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 2006, 38:485-489.
28. Adams L.A., Angulo P. Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease. Clin Liver Dis 2007, 11:25-35. [viii].